Healthcare company Medline said on Tuesday that its respiratory division has received an exclusive distribution agreement from Southmedic with access to the latter's latest breakthrough in advanced oxygen delivery technology in the OxyMask portfolio.

This agreement provides Medline with the non-exclusive access to Southmedic's OxyMask EtCO2 portfolio.

Through the partnership, the customers across the continuum of care gets greater access to high quality products that are designed with fit, function and compliance in mind.

Southmedic's OxyMask's revolutionary open design provides a cost effective solution for patients whose oxygen requirements may vary throughout their hospital stay.

Additionally, OxyMask's reduces the risk and dangers associated with aspiration or rebreathing CO2. It reduces the feelings of claustrophobia and allows unrestricted communication for patients. The possibility of skin breakdown is reduced and aids in the compliance of prescribed oxygen therapy by reducing interruptions, concluded the companies.